A randomized, double-blind, cross-over study to compare IPX054 to carbidopa-levodopa immediate-release tablets in subjects with Parkinson's Disease

Trial Profile

A randomized, double-blind, cross-over study to compare IPX054 to carbidopa-levodopa immediate-release tablets in subjects with Parkinson's Disease

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Feb 2017

At a glance

  • Drugs Levodopa/carbidopa (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Sponsors IMPAX Laboratories
  • Most Recent Events

    • 04 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top